Guardian Pharmacy Services, Inc. GRDN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.68% | 2.16% | 2.21% | 17.44% | 20.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.68% | 2.16% | 2.21% | 17.44% | 20.05% |
| Cost of Revenue | -5.57% | -1.62% | -1.76% | 14.97% | 19.40% |
| Gross Profit | 14.05% | 17.46% | 18.59% | 27.42% | 22.74% |
| SG&A Expenses | 3.88% | 25.36% | 8.59% | -2.43% | -64.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.05% | 2.80% | -0.09% | 12.20% | -13.88% |
| Operating Income | 49.08% | -12.94% | 56.97% | 124.99% | 116.13% |
| Income Before Tax | 56.20% | 136.69% | 39.58% | 91.72% | 115.74% |
| Income Tax Expenses | -2.57% | 104.02% | 23.90% | 124.52% | 3,898.86% |
| Earnings from Continuing Operations | 99.31% | 150.61% | 46.06% | 79.59% | 109.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -295.56% | -222.66% | -242.29% | -435.29% | 103.30% |
| Net Income | 90.26% | 142.21% | 40.72% | 75.19% | 108.72% |
| EBIT | 49.08% | -12.94% | 56.97% | 124.99% | 116.13% |
| EBITDA | 36.85% | -7.68% | 44.63% | 96.95% | 122.82% |
| EPS Basic | 86.65% | 137.39% | 37.89% | 289.56% | 108.58% |
| Normalized Basic EPS | 42.06% | 42.90% | 51.09% | 124.45% | 114.78% |
| EPS Diluted | 88.82% | 139.75% | 38.95% | 288.70% | 108.40% |
| Normalized Diluted EPS | 43.70% | 44.41% | 52.32% | 125.90% | 114.48% |
| Average Basic Shares Outstanding | 1.96% | 2.06% | 2.06% | 2.06% | 1.60% |
| Average Diluted Shares Outstanding | 0.76% | 1.00% | 1.24% | 1.42% | 3.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |